Control Post Endovascular Treatment of Aortic Aneurisms Through Magnetic Resonance and Ultrasound (SAFEVAR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03439423|
Recruitment Status : Recruiting
First Posted : February 20, 2018
Last Update Posted : February 22, 2018
|Condition or disease||Intervention/treatment|
|Abdominal Aortic Aneurism||Radiation: CT with contrast agent Diagnostic Test: MR without contrast agent Diagnostic Test: Color-Doppler Ultrasound Other: Questionnaire|
In this prospective observational study, 250 patients who underwent EVAR will be studied. They will be enrolled after referral for a CT with contrast agent at IRCCS Policlinico San Donato or at ASST Santi Paolo e Carlo. Those with absolute contraindications to RM will be excluded.
All enrolled subjects will undergo MR with contrast agent and color-Doppler ultrasound after CT. Before and after each examination, they will be submitted a questionnaire to evaluate their perception towards the former, and both costs and exposure deriving from such examinations will be evaluated along with patients' responses. Moreover, both CT and MR along with color-Doppler ultrasound will be analyzed with regards to human resources management, operational management, patients' clinical workflow and organization.
All CT examinations will be independently evaluated by two radiologists with 4- and 8-year expertise in thoracic or abdominal CT. Results obtained from CT examinations will be used as a reference standard using the "worst case scenario" method: if either reader reported endoleak, the CT will be considered positive. The more experienced reader will anonymously and randomly repeat CT evaluation after 1 month.
For CMR examinations, a 15-minute protocol will be used on a 1.5-T device. The following sequences will be performed:
- steady state free-precession (true-FISP)
- half-Fourier single shot spin-echo (HASTE) All examinations will be independently and blindly evaluated by the same two radiologists as CT examinations, and they will be considered positive if areas (even smaller than 5 mm) of alterate signal in comparison to surrounding muscle in the same slice are present inside the aneurismatic sac. The more experienced reader will anonymously and randomly repeat CT evaluation after 1 month.
Color-Doppler ultrasound will be performed with a 1-5 MHz probe, by a radiologist with 7-year expertise in aortic ultrasound, blinded to MR and CT results. Ultrasound images will be evaluated both directly and through spectral flow study.
The sample size was calculated assuming an alpha error of 5%, 90% power and 10% endoleak prevalence. In order to prove a negative predictive value of MR without contrast agent and color-Doppler ultrasound not inferior to 90%, 250 patients should be enrolled.
|Study Type :||Observational|
|Estimated Enrollment :||250 participants|
|Official Title:||Controllo Dopo Trattamento Endovascolare di Aneurismi Aortici Mediante Risonanza Magnetica Senza Mezzo di Contrasto ed Ecografia Con Color-doppler: Accuratezza Diagnostica, Analisi Costo-efficacia e Impatto Sul Management Del Paziente|
|Actual Study Start Date :||March 9, 2016|
|Estimated Primary Completion Date :||March 9, 2022|
|Estimated Study Completion Date :||June 9, 2022|
|Patients who underwent EVAR||
Radiation: CT with contrast agent
Diagnostic Test: MR without contrast agent
on 1.5-T unit, with the following sequences:
Diagnostic Test: Color-Doppler Ultrasound
regarding their perception of examinations
- Sensitivity and negative predictive value [ Time Frame: 2 year ]
CT exams with contrast agent will be interpreted by 2 independent and blinded radiologists. The results of enhanced CT will be used as reference standard basing to "worst case scenario" method, i.e. it will be considered positive when one or both readers will report the presence of endoleak. Moreover, in the same way, the most expert reader will repeat the reading after 1 month compared to the first reading. Enhanced 1.5-T MRI will be conducted using true-FISP and HASTE sequences.
The same 2 readers will evaluate the exams comparing to the previous CT exams. Images will be considered positive for the presence of endoleak if inside the aneurysmal sac excluded there will be an area of altered signal compared to adjacent muscles displayed in the same layers. The most experienced reader will repeat the exam reading 1 month later.
The 1,5 MHz Color-Doppler ultrasound will be performed by a radiologist with 7 y of experience in vascular ultrasound of the aorta, blinded to the enhanced CT.
- Efficacy of the two diagnostic approaches [ Time Frame: 2 year ]A systematic review of the literature will be performed and the data will be used to compare the efficacy of the two diagnostic approaches.
- Patient's perception [ Time Frame: 2 year ]To evaluate and compare the patient's perception of the examination performed (both MR and CT-free MCD and CT), we will use a EuroQoL5 questionnaire. Patients will be asked to complete the questionnaire before and after each survey. Regarding the economic costs, we will compare the main medical costs (equipment, drugs, used devices, personnel, etc.) to complete the two different diagnostic strategies compared.
- Economic costs [ Time Frame: 2 year ]Regarding the economic costs, we will compare the main medical costs (equipment, drugs, used devices, personnel, etc.) to complete the two different diagnostic strategies compared.
- Patient management [ Time Frame: 2 year ]To investigate how the introduction of new technologies in the health field questions the traditional organizational dynamics, two treatments will be examined and compared in terms of human resources, operational management of the treatment process, clinical pathway of the patient and organizational structure.
- Involvement of professionals [ Time Frame: 2 year ]All the professionals involved in the new diagnostic strategy will be interviewed to identify the organizational strengths and weaknesses related to the new diagnostic strategy in order to allow ad-hoc interventions to improve the process.
- Patient acceptance and satisfaction [ Time Frame: 2 year ]Regarding the level of patient acceptance and satisfaction, a questionnaire will be proposed and, the results will provide important information to identify the strengths and weaknesses of the treatment and to refine the procedure in order to maximize patient satisfaction.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03439423
|Contact: Francesco Secchi, MD PhDemail@example.com|
|IRCCS Policlinico San Donato||Recruiting|
|San Donato Milanese, Milan, Italy, 20097|
|Contact: Francesco Secchi, MD PhD firstname.lastname@example.org|